{"entity":{"type":"insider","cik":"0001805359","url":"/insider/0001805359","json_url":"/insider/0001805359.json","name":"Hayes Christopher G.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2021-06-07","last":"2025-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Hayes Christopher G.","source":"filing","n_filings":8,"first_seen":"2021-06-07","last_seen":"2025-03-18"}],"transactions":[{"id":4433385,"accession":"0001415889-25-008505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008505","line_url":"/filing/0001415889-25-008505#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4315.0,"shares_display":"4,315","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":2804.75,"total_display":"2,804.75","total_whole":"2,805","shares_owned_after":176458.0,"shares_owned_after_display":"176,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":2900447,"accession":"0001415889-24-022427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-022427","line_url":"/filing/0001415889-24-022427#line-2","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9530.0,"shares_display":"9,530","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":23443.8,"total_display":"23,443.80","total_whole":"23,444","shares_owned_after":105773.0,"shares_owned_after_display":"105,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-28","scope":"insider"},{"id":2900441,"accession":"0001415889-24-022427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-022427","line_url":"/filing/0001415889-24-022427#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26183.0,"shares_display":"26,183","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":69646.78,"total_display":"69,646.78","total_whole":"69,647","shares_owned_after":115303.0,"shares_owned_after_display":"115,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":2101708,"accession":"0001415889-24-019970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019970","line_url":"/filing/0001415889-24-019970#line-2","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91.0,"shares_display":"91","price_per_share":6.98,"price_display":"6.98","price_state":"stated","total_value":635.18,"total_display":"635.18","total_whole":"635","shares_owned_after":141486.0,"shares_owned_after_display":"141,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-23","filed_date":"2024-07-23","scope":"insider"},{"id":2101704,"accession":"0001415889-24-019970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019970","line_url":"/filing/0001415889-24-019970#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (CHIEF LEGAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF LEGAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF LEGAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21649.0,"shares_display":"21,649","price_per_share":7.06,"price_display":"7.06","price_state":"stated","total_value":152841.94,"total_display":"152,841.94","total_whole":"152,842","shares_owned_after":141577.0,"shares_owned_after_display":"141,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-22","filed_date":"2024-07-23","scope":"insider"},{"id":7923816,"accession":"0001209191-23-055527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-055527","line_url":"/filing/0001209191-23-055527#line-2","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11558.0,"shares_display":"11,558","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":34327.26,"total_display":"34,327.26","total_whole":"34,327","shares_owned_after":123226.0,"shares_owned_after_display":"123,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-16","scope":"insider"},{"id":7923814,"accession":"0001209191-23-055527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055527","line_url":"/filing/0001209191-23-055527#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22141.0,"shares_display":"22,141","price_per_share":2.93,"price_display":"2.93","price_state":"stated","total_value":64873.13,"total_display":"64,873.13","total_whole":"64,873","shares_owned_after":134784.0,"shares_owned_after_display":"134,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":8154966,"accession":"0001209191-23-043306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043306","line_url":"/filing/0001209191-23-043306#line-2","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33789.0,"shares_display":"33,789","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":163200.87,"total_display":"163,200.87","total_whole":"163,201","shares_owned_after":81925.0,"shares_owned_after_display":"81,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-25","scope":"insider"},{"id":6631107,"accession":"0001209191-22-041835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041835","line_url":"/filing/0001209191-22-041835#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":25500.0,"total_display":"25,500.00","total_whole":"25,500","shares_owned_after":15714.0,"shares_owned_after_display":"15,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-11","scope":"insider"},{"id":6211350,"accession":"0001209191-22-040616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-040616","line_url":"/filing/0001209191-22-040616#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5714.0,"shares_display":"5,714","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":11999.4,"total_display":"11,999.40","total_whole":"11,999","shares_owned_after":8214.0,"shares_owned_after_display":"8,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-05","scope":"insider"},{"id":4227719,"accession":"0001209191-21-038481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038481","line_url":"/filing/0001209191-21-038481#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001805359","owner_name":"Hayes Christopher G.","owner_display_name":"Hayes Christopher G.","owner_url":"/insider/0001805359","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":9.79,"price_display":"9.79","price_state":"stated","total_value":24475.0,"total_display":"24,475.00","total_whole":"24,475","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660334","name":"Verrica Pharmaceuticals Inc.","url":"/issuer/0001660334","role":"Officer (CHIEF LEGAL OFFICER)","n_filings":8,"first_seen":"2021-06-07","last_seen":"2025-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001805359","retrieved_at":"2026-08-23T10:15:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}